Magnus Gisslen
-
Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal
injury.
Wei Jiang, Zhenwu Luo, Sophie Stephenson, Hong Li, Clara Di Germanio, Philip J Norris, Dietmar Fuchs, Henrik Zetterberg, Magnus Gisslén, Richard W Price
The Journal of infectious diseases - 2021-01-01 -
No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS
62).
Juan M Tiraboschi, Jhon Rojas, Henrik Zetterberg, Kaj Blennow, Jordi Niubo, Johanna Gostner, Antonio Navarro-Alcaraz, Camila Piatti, Dietmar Fuchs, Magnus Gisslén, Raul Rigo-Bonnin, Esteban Martinez, Daniel Podzamczer
The Journal of infectious diseases - 2021-01-01 -
Higher plasma drug levels in elderly people living with HIV treated with
darunavir
Erika Tyrberg, Arvid Edén, J. Eriksen, S. Nilsson, C. J. Treutiger, A. Thalme, Åsa Mellgren, Magnus Gisslén, Lars-Magnus Andersson
PLoS ONE - 2021-01-01 -
Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and
synthesis.
Arvid Edén, Joel Simrén, Henrik Zetterberg, Magnus Gisslén
Journal of neurochemistry - 2021-01-01 -
Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral
therapy.
Albert M Anderson, Suprateek Kundu, Bin Tang, Florin Vaida, Oluwakemi Okwuegbuna, Daniel McClernon, Mariana Cherner, Reena Deutsch, Debra Cookson, Melanie Crescini, Igor Grant, Henrik Zetterberg, Kaj Blennow, Magnus Gisslén, Ronald J Ellis, Scott L Letendre
Journal of neuroimmunology - 2021-01-01 -
Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19
patients
Susannah Leach, Ali M Harandi, Tomas Bergström, Lars-Magnus Andersson, Staffan Nilsson, L. van der Hoek, Magnus Gisslén
Journal of Medical Virology - 2021-01-01 -
Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical
COVID-19.
Aylin Yilmaz, Emelie Marklund, Maria Andersson, Staffan Nilsson, Lars-Magnus Andersson, Magnus Lindh, Magnus Gisslén
The Journal of infectious diseases - 2021-01-01 -
CSF biomarkers in patients with COVID-19 and neurological symptoms: A case
series.
Arvid Edén, Nelly Kanberg, Johanna Gostner, Dietmar Fuchs, Lars Hagberg, Lars-Magnus Andersson, Magnus Lindh, Richard W Price, Henrik Zetterberg, Magnus Gisslén
Neurology - 2021-01-01 -
CLINICAL UTILITY OF β-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE
SYMPTOMS.
Jaime H Vera, Nicholas Eftychiou, Matti Schuerer, Michael Rullmann, Henryk Barthel, Magnus Gisslén, Henrik Zetterberg, Osama Sabri, Kaj Blennow, Clara O'Brien, Sube Banerjee, Sabina Dizdarevic
Journal of acquired immune deficiency syndromes (1999) - 2021-01-01 -
Laboratory diagnostic value of neopterin measurements in patients with COVID-19
infection
D. Fuchs, Magnus Gisslén
Pteridines - 2021-01-01 -
Contagiousness in treated HIV-1
infection
J. Eriksen, J. Albert, M. Axelsson, T. Berglund, J. Brannstrom, H. Gaines, Magnus Gisslén, P. Groon, P. Hagstam, L. Naver, K. Pettersson, J. Stenkvist, A. Sonnerborg, A. Tegnell
Infectious Diseases - 2021-01-01 -
Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with
COVID-19.
Fredy Saguti, Ellen Magnil, Lucica Enache, Marianela Patzi Churqui, Anette Johansson, Douglas Lumley, Fredrik Davidsson, Leif Dotevall, Ann Mattsson, Edward Trybala, Martin Lagging, Magnus Lindh, Magnus Gisslén, Thomas Brezicka, Kristina Nyström, Helene Norder
Water research - 2021-01-01 -
Serum neopterin levels in relation to mild and severe
COVID-19.
Josefina Robertson, Johanna M Gostner, Staffan Nilsson, Lars-Magnus Andersson, Dietmar Fuchs, Magnus Gisslén
BMC infectious diseases - 2020-01-01 -
Impact of insufficient ACE2 products and late enterocyt regeneration in severe
covid-19
Bengt Nellgård, Magnus Gisslén, Mats Börjesson, Martin Lagging, D Kalla, J Savnvil
Science - 2020-01-01 -
Response to: 'How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive
population?'
A. Winston, A Cotter, Magnus Gisslén, Pwg Mallon, P Cinque
HIV medicine - 2020-01-01 -
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with
HIV-1.
Michael J Peluso, Cassandra Thanh, Cecilia A Prator, Louise E Hogan, Victor M Arechiga, Sophie Stephenson, Philip J Norris, Clara Di Germanio, Dietmar Fuchs, Henrik Zetterberg, Steven G Deeks, Magnus Gisslén, Richard W Price, Timothy J Henrich
Journal of virus eradication - 2020-01-01 -
Neurochemical evidence of astrocytic and neuronal injury commonly found in
COVID-19.
Nelly Kanberg, Nicholas J. Ashton, Lars-Magnus Andersson, Aylin Yilmaz, Magnus Lindh, Staffan Nilsson, Richard W Price, Kaj Blennow, Henrik Zetterberg, Magnus Gisslén
Neurology - 2020-01-01 -
Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV
Infection.
Albert M Anderson, Jeong Hoon Jang, Kirk A Easley, Dietmar Fuchs, Magnus Gisslén, Henrik Zetterberg, Kaj Blennow, Ronald J Ellis, Donald Franklin, Robert K Heaton, Igor Grant, Scott L Letendre
Journal of acquired immune deficiency syndromes - 2020-01-01 -
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG
non-responders.
Emelie Marklund, Susannah Leach, Hannes Axelsson, Kristina Nyström, Helene Norder, Mats Bemark, Davide Angeletti, Anna Lundgren, Staffan Nilsson, Lars-Magnus Andersson, Aylin Yilmaz, Magnus Lindh, Jan-Åke Liljeqvist, Magnus Gisslén
PloS one - 2020-01-01 -
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and
discordance.
Lars Hagberg, Richard W Price, Henrik Zetterberg, Dietmar Fuchs, Magnus Gisslén
PloS one - 2020-01-01 -
Antiretroviral treatment for HIV infection: Swedish recommendations
2019
J. Eriksen, C. Carlander, J. Albert, L. Flamholc, Magnus Gisslén, L. Naver, V. Svedhem, Aylin Yilmaz, A. Sonnerborg
Infectious Diseases - 2020-01-01 -
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment
interruption.
Marie-Angélique De Scheerder, Clarissa Van Hecke, Henrik Zetterberg, Dietmar Fuchs, Nele De Langhe, Sofie Rutsaert, Bram Vrancken, Wim Trypsteen, Ytse Noppe, Bea Van Der Gucht, Jolanda Pelgrom, Filip Van Wanzeele, Sarah Palmer, Philippe Lemey, Magnus Gisslén, Linos Vandekerckhove
The Journal of antimicrobial chemotherapy - 2020-01-01 -
Defining cerebrospinal fluid HIV RNA escape: editorial review
AIDS.
Alan Winston, Andrea Antinori, Paola Cinque, Howard S Fox, Magnus Gisslén, Timothy J Henrich, Scott Letendre, Deborah Persaud, Richard W Price, Serena Spudich
AIDS (London, England) - 2019-01-01 -
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1
infection
Magnus Gisslén, Amanda Heslegrave, E. Veleva, Aylin Yilmaz, Lars-Magnus Andersson, Lars Hagberg, S. Spudich, D. Fuchs, R. W. Price, Henrik Zetterberg
Neurology-Neuroimmunology & Neuroinflammation - 2019-01-01 -
Potential for early antiretroviral therapy to reduce central nervous system HIV-1
persistence.
Serena Spudich, Julia Peterson, Dietmar Fuchs, Richard W Price, Magnus Gisslén
AIDS (London, England) - 2019-01-01 -
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide
fumarate.
Linn Hermansson, Aylin Yilmaz, Richard W Price, Staffan Nilsson, Scott McCallister, Tariro Makadzange, Moupali Das, Henrik Zetterberg, Kaj Blennow, Magnus Gisslén
PloS one - 2019-01-01 -
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and
Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen, José C Alvarez-Cermeño, Ulf Andreasson, Markus Axelsson, David C Bäckström, Ales Bartos, Maria Bjerke, Adam Boxer, Lou Brundin, Joachim Burman, Tove Christensen, Lenká Fialová, Lars Forsgren, Jette L Frederiksen, Magnus Gisslén, Elizabeth Gray, Martin Gunnarsson, Sara Hall, Oskar Hansson, Megan Herbert, Joel Jakobsson, Jan Jessen-Krut, Shorena Janelidze, Gudmundur Johannsson, Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kuhle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching-Hua Lu, Jan Lycke, Nadia K Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke H Meeter, Sanjay R Mehta, Signe Modvig, Tomas Olsson, Ross W Paterson, Josué Pérez-Santiago, Fredrik Piehl, Yolande A L Pijnenburg, Okko T Pyykkö, Oskar Ragnarsson, Julio C Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole S Scherling, Jonathan M Schott, Finn T Sellebjerg, Isabella L Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R Turner, John C van Swieten, Mattias Vågberg, Marcel M Verbeek, Luisa M Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsö, Edward J Wild, Kaj Blennow
JAMA neurology - 2019-01-01 -
Antiretroviral treatment of acute HIV infection normalizes CSF markers of CNS inflammation. A consequence of reduced CNS
reservoir?
Magnus Gisslén, Peter W Hunt
The Journal of infectious diseases - 2019-01-01 -
HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded
Cells.
Sarah B Joseph, Laura P Kincer, Natalie M Bowman, Chris Evans, Michael J Vinikoor, Christopher K Lippincott, Magnus Gisslén, Serena Spudich, Prema Menezes, Kevin Robertson, Nancie Archin, Angela Kashuba, Joseph J Eron, Richard W Price, Ronald Swanstrom
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 2019-01-01 -
Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected
individuals.
Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur, Beau K Nakamoto, Melissa Agsalda-Garcia, Bruce Shiramizu, Cecilia M Shikuma, Magnus Gisslén, Richard W Price, Victor Valcour, Lishomwa C Ndhlovu
Journal of neurovirology - 2019-01-01 -
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with
HIV-1
Joseph J. Eron, C. Orkin, Douglas Cunningham, Federico Pulido, Frank A. Post, Stéphane De Wit, E. Lathouwers, Veerle Hufkens, John Jezorwski, Romana Petrovic, Kimberley Brown, E. Van Landuyt, M. Opsomer, S. De Wit, E. Florence, M. Moutschen, E. Van Wijngaerden, L. Vandekerckhove, B. Vandercam, J. Brunetta, B. Conway, M. Klein, D. Murphy, A. Rachlis, S. Shafran, S. Walmsley, F. Ajana, L. Cotte, P. M. Girardy, C. Katlama, J. M. Molina, I. Poizot-Martin, F. Raffi, D. Rey, J. Reynes, E. Teicher, Y. Yazdanpanah, J. Gasiorowski, W. Halota, A. Horban, A. Piekarska, A. Witor, J. R. Arribas, I. Perez-Valero, J. Berenguer, J. Casado, J. M. Gatell, F. Gutierrez, M. J. Galindo, M. D.M. Gutierrez, J. A. Iribarren, H. Knobel, E. Negredo, J. A. Pineda, D. Podzamczer, J. Portilla Sogorb, F. Pulido, C. Ricart, A. Rivero, I. Santos Gil, A. Blaxhult, L. Flamholc, Magnus Gisslén, A. Thalme, J. Fehr, A. Rauch, M. Stoeckle, A. Clarke, B. G. Gazzard, M. A. Johnson, C. Orkin, A. Ustianowski, L. Waters, J. Bailey, P. Benson, L. Bhatti, I. Brar, U. F. Bredeek, C. Brinson, G. Crofoot, D. Cunningham, E. DeJesus, C. Dietz, R. Dretler, J. Eron, F. Felizarta, C. Fichtenbaum, J. Gallant, J. Gathe, D. Hagins, S. Henn, W. K. Henry, G. Huhn, M. Jain, C. Lucasti, C. Martorell, C. McDonald, A. Mills, J. Morales-Ramirez
Antiviral Research - 2019-01-01 -
Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1
infection
Aylin Yilmaz, Mellgren, Mellgren,, D. Fuchs, Staffan Nilsson, Kaj Blennow, Henrik Zetterberg, Magnus Gisslén
Infectious Diseases - 2019-01-01 -
Is low-level HIV-1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular
disease?
O. Elvstam, P. Medstrand, M. Jansson, P. E. Isberg, Magnus Gisslén, P. Björkman
HIV Medicine - 2019-01-01 -
Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry
study
J. Soderholm, Aylin Yilmaz, A. Svenningsson, K. Busch, Rune Wejstål, A. Brolund, J. Kovamees, M. Sallberg, Martin Lagging, Magnus Gisslén
Journal of Neurology - 2019-01-01 -
Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-beta-D-glucan in HIV-infected patients: a retrospective case control
study
Helena Hammarström, Anna Grankvist, Isabell Broman, Nahid Kondori, Christine Wennerås, Magnus Gisslén, Vanda Friman
BMC Infectious Diseases - 2019-01-01 -
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological
Disorders.
Aylin Yilmaz, Dietmar Fuchs, Richard W Price, Serena Spudich, Kaj Blennow, Henrik Zetterberg, Magnus Gisslén
Current HIV/AIDS reports - 2019-01-01 -
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV
infection
Linn Hermansson, Aylin Yilmaz, M Axelsson, Kaj Blennow, D. Fuchs, Lars Hagberg, Jan Lycke, Henrik Zetterberg, Magnus Gisslén
Journal of Neuroinflammation - 2019-01-01 -
Persistent CNS immune activation following > 10 years of effective HIV antiretroviral
treatment.
Gustaf Ulfhammer, Arvid Edén, Åsa Mellgren, Dietmar Fuchs, Henrik Zetterberg, Lars Hagberg, Staffan Nilsson, Aylin Yilmaz, Magnus Gisslén
AIDS (London, England) - 2018-01-01 -
Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral
therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton, Henrik Zetterberg, Kaj Blennow, Magnus Gisslén, Scott L. Letendre
Journal of neurovirology - 2018-01-01 -
Blood Telomere Length Changes after Ritonavir-Boosted Darunavir Combined with Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected with
HIV-1
N. Stella-Ascariz, R. Montejano, J. Rodriguez-Centeno, B. Alejos, C. Schwimmer, J. I. Bernardino, B. Rodes, C. Allavena, C. Hoffmann, Magnus Gisslén, R. De Miguel, A. Esteban-Cantos, C. Wallet, F. Raffi, J. R. Arribas
Journal of Infectious Diseases - 2018-01-01 -
Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in
Sweden.
Zaake de Coninck, Laith Hussain-Alkhateeb, Göran Bratt, Anna Mia Ekström, Magnus Gisslén, Max Petzold, Veronica Svedhem
AIDS patient care and STDs - 2018-01-01 -
Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations
2017
L. Naver, J. Albert, C. Carlander, L. Flamholc, Magnus Gisslén, O. Karlstrom, V. Svedhem-Johansson, A. Sonnerborg, K. Westling, Aylin Yilmaz, K. Pettersson
Infectious Diseases - 2018-01-01 -
Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily
administration
A. Calcagno, C. Pinnetti, A. De Nicolo, E. Scarvaglieri, Magnus Gisslén, M. Tempestilli, A. D'Avolio, V. Fedele, G. Di Perri, A. Antinori, S. Bonora
British Journal of Clinical Pharmacology - 2018-01-01 -
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI
mutations
Erik Sörstedt, C. Carlander, L. Flamholc, B. Hejdeman, V. Svedhem, A. Sonnerborg, Magnus Gisslén, Aylin Yilmaz
International Journal of Antimicrobial Agents - 2018-01-01 -
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in
Sweden
E. Andersson, A. Nordquist, J. Esbjörnsson, L. Flamholc, Magnus Gisslén, B. Hejdeman, G. Marrone, H. Norrgren, V. Svedhem, S. Wendahl, J. Albert, A. Sönnerborg
AIDS - 2018-01-01 -
Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System
Reservoir?
P. D. Burbelo, R. W. Price, Lars Hagberg, H. Hatano, S. Spudich, S. G. Deeks, Magnus Gisslén
Journal of Infectious Diseases - 2018-01-01 -
Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid
biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole, Ferdinand W Wit, Matthan W A Caan, Neeltje A Kootstra, Dietmar Fuchs, Henrik Zetterberg, Charles B L M Majoie, Peter Portegies, Alan Winston, David J Sharp, Magnus Gisslén, Peter Reiss
The Journal of infectious diseases - 2018-01-01 -
Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1
infection.
Michael J Peluso, Victor Valcour, Nittaya Phanuphak, Jintanat Ananworanich, James Lk Fletcsher, Thep Chalermchai, Shelly J Krebs, Merlin L Robb, Joanna Hellmuth, Magnus Gisslén, Henrik Zetterberg, Serena Spudich
AIDS (London, England) - 2017-01-01 -
Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral
Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson, Dieter J Meyerhoff, Henrik Zetterberg, Magnus Gisslén, Richard W Price, Serena Spudich
The Journal of infectious diseases - 2017-01-01 -
Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1
DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh, Bo Svennerholm, Magnus Gisslén
International Journal of Virology and AIDS - 2017-01-01 -
High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal
Fluid
T. Booiman, F. W. Wit, I. Maurer, D. De Francesco, C. A. Sabin, A. M. Harskamp, M. Prins, P. Garagnani, C. Pirazzini, C. Franceschi, D. Fuchs, Magnus Gisslén, A. Winston, P. Reiss, N. A. Kootstra
Open Forum Infectious Diseases - 2017-01-01 -
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative
controls.
Aylin Yilmaz, Kaj Blennow, Lars Hagberg, Staffan Nilsson, Richard W Price, Judith Schouten, Serena Spudich, Jonathan Underwood, Henrik Zetterberg, Magnus Gisslén
Expert review of molecular diagnostics - 2017-01-01 -
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected
patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman, L. Flamholc, A. Sonnerborg
Plos One - 2017-01-01 -
Recent increased identification and transmission of HIV-1 unique recombinant forms in
Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt, G. Marrone, A. Sonnerborg
Scientific Reports - 2017-01-01 -
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau
(p-tau).
Jan Jessen Krut, Richard W Price, Henrik Zetterberg, Dietmar Fuchs, Lars Hagberg, Aylin Yilmaz, Paola Cinque, Staffan Nilsson, Magnus Gisslén
Virulence - 2017-01-01 -
Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral
treatment
O. Elvstam, P. Medstrand, Aylin Yilmaz, P. E. Isberg, Magnus Gisslén, P. Bjorkman
Plos One - 2017-01-01 -
Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care
targets.
Magnus Gisslén, V Svedhem, L Lindborg, L Flamholc, H Norrgren, S Wendahl, M Axelsson, A Sönnerborg
HIV medicine - 2017-01-01 -
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance
pathway.
Erik Portelius, Niklas Mattson, Josef Pannee, Henrik Zetterberg, Magnus Gisslén, Hugo Vanderstichele, Eleni Gkanatsiou, Gabriela A N Crespi, Michael W Parker, Luke A Miles, Johan Gobom, Kaj Blennow
Molecular neurodegeneration - 2017-01-01 -
Antiretroviral treatment for HIV infection: Swedish recommendations
2016.
Jaran Eriksen, Jan Albert, Anders Blaxhult, Christina Carlander, Leo Flamholc, Magnus Gisslén, Filip Josephson, Olof Karlström, Lars Navér, Veronica Svedhem, Aylin Yilmaz, Anders Sönnerborg
Infectious diseases (London, England) - 2017-01-01 -
HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV
2009-2014
A. Haggblom, S. Lindback, Magnus Gisslén, L. Flamholc, B. Hejdeman, A. Palmborg, A. Leval, E. Herweijer, S. Valgardsson, V. Svedhem
Plos One - 2017-01-01 -
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral
Therapy
Hans Gaines, Jan Albert, Maria Axelsson, Torsten Berglund, Magnus Gisslén, Anders Sönnerborg, Anders Blaxhult, Gordana Bogdanovic, Maria Brytting, Christina Carlander, Leo Flamholc, Per Follin, Axana Haggar, Per Hagstam, Marcus Johansson, Lars Navér, Jenny Persson Blom, Agneta Samuelson, Helena Ström, Veronica Svedhem Johansson, Martin Sundqvist, Karin Tegmark Wisell, Anders Tegnell, Rigmor Thorstensson
Infectious diseases (London, England) - 2016-01-01 -
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD,
USA.
Jeymohan Joseph, Paola Cinque, Deborah Colosi, Ameet Dravid, Luminita Ene, Howard Fox, Dana Gabuzda, Magnus Gisslén, Sarah Beth Joseph, Scott Letendre, Shibani S Mukerji, Avindra Nath, Ignacio Perez-Valero, Deborah Persaud, Richard W Price, Vasudev R Rao, Ned Sacktor, Ronald Swanstrom, Alan Winston, Valerie Wojna, Edwina Wright, Serena Spudich
Journal of virus eradication - 2016-01-01 -
HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic
Countries
J. Esbjornsson, M. Mild, A. Audelin, J. Fonager, H. Skar, L. B. Jorgensen, K. Liitsola, P. Bjorkman, G. Bratt, Magnus Gisslén, A. Sonnerborg, C. Nielsen, P. Medstrand, J. Albert
Virus Evolution - 2016-01-01 -
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal
Study.
Arvid Edén, Staffan Nilsson, Lars Hagberg, Dietmar Fuchs, Henrik Zetterberg, Bo Svennerholm, Magnus Gisslén
The Journal of infectious diseases - 2016-01-01 -
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in
HIV.
Birgitta Anesten, Aylin Yilmaz, Henrik Zetterberg, Lars Hagberg, Staffan Nilsson, Bruce J Brew, Dietmar Fuchs, Richard W Price, Magnus Gisslén
Neurology, Neuroimmunology & Neuroinflammation - 2016-01-01 -
HIV-1 low copy viral sequencing-a prototype
assay
Tomas Mellberg, Jon Krabbe, Magnus Gisslén, Bo Svennerholm
Infectious Diseases - 2016-01-01 -
Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216)
135-140].
Magnus Gisslén, Richard W Price, Ulf Andreasson, Niklas Norgren, Staffan Nilsson, Lars Hagberg, Dietmar Fuchs, Serena Spudich, Kaj Blennow, Henrik Zetterberg
EBioMedicine - 2016-01-01 -
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated
patients.
Francesca Ferretti, Alba Bigoloni, Laura Passeri, Laura Galli, Valeria Longo, Simonetta Gerevini, Vincenzo Spagnuolo, Magnus Gisslén, Henrik Zetterberg, Dietmar Fuchs, Dario Cattaneo, Giada Caramatti, Adriano Lazzarin, Paola Cinque, Antonella Castagna
Medicine - 2016-01-01 -
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV
Infection
Erika Ahlgren, Lars Hagberg, Dietmar Fuchs, Lars-Magnus Andersson, Staffan Nilsson, Henrik Zetterberg, Magnus Gisslén
PLoS ONE - 2016-01-01 -
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized
Trials
A. H. Borges, A. Lundh, B. Tendal, J. A. Bartlett, N. Clumeck, D. Costagliola, E. S. Daar, P. Echeverria, Magnus Gisslén, T. B. Huedo-Medina, M. D. Hughes, K. H. Hullsiek, P. Khabo, S. Komati, P. Kumar, S. Lockman, R. D. MacArthur, F. Maggiolo, A. Matteelli, J. M. Miro, S. Oka, K. Petoumenos, R. L. Puls, S. A. Riddler, P. E. Sax, J. Sierra-Madero, C. Torti, J. D. Lundgren
Clinical Infectious Diseases - 2016-01-01 -
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA
levels
Erik Sörstedt, Staffan Nilsson, A. Blaxhult, Magnus Gisslén, L. Flamholc, A. Sonnerborg, Aylin Yilmaz
BMC Infectious Diseases - 2016-01-01 -
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive
Impairment
Arvid Edén, T. D. Marcotte, R. K. Heaton, Staffan Nilsson, Henrik Zetterberg, D. Fuchs, D. Franklin, R. W. Price, I. Grant, S. L. Letendre, Magnus Gisslén
Plos One - 2016-01-01 -
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional
study
S. Jespersen, K. K. Pedersen, Birgitta Anesten, Henrik Zetterberg, D. Fuchs, Magnus Gisslén, Lars Hagberg, M. Troseid, S. D. Nielsen
Bmc Infectious Diseases - 2016-01-01 -
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional
Study
Magnus Gisslén, Richard W. Price, Ulf Andreasson, Niklas Norgren, Staffan Nilsson, Lars Hagberg, Dietmar Fuchs, Serena Spudich, Kaj Blennow, Henrik Zetterberg
EBioMedicine - 2016-01-01 -
Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe
immunodeficiency.
Ulf Karlsson, Johanna Repits, Liselotte Antonsson, Erik Cederfjäll, Bengt Ljungberg, Martin Ålenius, Alan Sabirsh, Magnus Gisslén, Joakim Esbjörnsson, Marianne Jansson
Journal of acquired immune deficiency syndromes (1999) - 2016-01-01 -
Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral
suppression
M. S. Di Yacovo, J. Molto, E. Ferrer, A. Curran, L. Else, Magnus Gisslén, B. Clotet, J. M. Tiraboschi, J. Niubo, A. Vila, Henrik Zetterberg, D. Back, D. Podzamczer
Journal of Antimicrobial Chemotherapy - 2015-01-01 -
Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV
Infection.
Michael J Peluso, Victor Valcour, Jintanat Ananworanich, Pasiri Sithinamsuwan, Thep Chalermchai, James L K Fletcher, Sukalya Lerdlum, Nitiya Chomchey, Bonnie Slike, Napapon Sailasuta, Magnus Gisslén, Henrik Zetterberg, Serena Spudich
The Journal of infectious diseases - 2015-01-01 -
The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's
disease
S. Makitalo, Åsa Mellgren, Ellen Borgh, L. Kilander, Tobias Skillbäck, Henrik Zetterberg, Magnus Gisslén
Aids Research and Therapy - 2015-01-01 -
Cerebrospinal Fluid HIV Escape from Antiretroviral
Therapy
F. Ferretti, Magnus Gisslén, P. Cinque, R. W. Price
Current Hiv/Aids Reports - 2015-01-01 -
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1
Patients
Jan Jessen Krut, Tomas Mellberg, R.W. Price, Lars Hagberg, D. Fuchs, Lars Rosengren, Staffan Nilsson, Henrik Zetterberg, Magnus Gisslén
PLoS ONE - 2014-01-01 -
Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and
detection.
Julia Peterson, Magnus Gisslén, Henrik Zetterberg, Dietmar Fuchs, Barbara L Shacklett, Lars Hagberg, Constantin T Yiannoutsos, Serena S Spudich, Richard W Price
PloS one - 2014-01-01 -
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations
2013.
Lars Navér, Jan Albert, Ylva Böttiger, Christina Carlander, Leo Flamholc, Magnus Gisslén, Filip Josephson, Olof Karlström, Lena Lindborg, Veronica Svedhem-Johansson, Bo Svennerholm, Anders Sönnerborg, Aylin Yilmaz, Karin Pettersson
Scandinavian journal of infectious diseases - 2014-01-01 -
Progressive increase in central nervous system immune activation in untreated primary HIV-1
infection
J. Suh, E. Sinclair, J. Peterson, E. Lee, T. C. Kyriakides, F. Y. Li, Lars Hagberg, D. Fuchs, R. W. Price, Magnus Gisslén, S. Spudich
Journal of Neuroinflammation - 2014-01-01 -
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune
activation
V. Dahl, J. Peterson, D. Fuchs, Magnus Gisslén, S. Palmer, R. W. Price
Aids - 2014-01-01 -
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral
Therapy
J. Albert, T. Berglund, Magnus Gisslén, P. Groon, A. Sonnerborg, A. Tegnell, A. Alexandersson, I. Berggren, A. Blaxhult, M. Brytting, C. Carlander, J. Carlson, L. Flamholc, P. Follin, A. Haggar, F. Hansdotter, F. Josephson, O. Karlstrom, F. Liljeros, L. Naver, K. Pettersson, V. S. Johansson, Bo Svennerholm, Petra Tunbäck, K. Widgren
Scandinavian Journal of Infectious Diseases - 2014-01-01 -
An example of genetically distinct HIV-1 variants in cerebrospinal fluid and plasma during suppressive
therapy.
Viktor Dahl, Magnus Gisslén, Lars Hagberg, Julia Peterson, Wei Shao, Serena Spudich, Richard W Price, Sarah Palmer
The Journal of infectious diseases - 2014-01-01 -
Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three
Decades.
Ujjwal Neogi, Amanda Häggblom, Michele Santacatterina, Göran Bratt, Magnus Gisslén, Jan Albert, Anders Sonnerborg
PloS one - 2014-01-01 -
Treatment of HIV in the Central Nervous
System
Aylin Yilmaz, Magnus Gisslén
Seminars in Neurology - 2014-01-01 -
Evolving Character of Chronic Central Nervous System HIV
Infection
Richard W. Price, Serena S. Spudich, Julia Peterson, Sarah Joseph, Dietmar Fuchs, Henrik Zetterberg, Magnus Gisslén, Ronald Swanstrom
Seminars in Neurology - 2014-01-01 -
Kinetics of Microbial Translocation Markers in Patients on Efavirenz or Lopinavir/r Based Antiretroviral
Therapy
J. Vesterbacka, P. Nowak, B. Barqasho, S. Abdurahman, J. Nystrom, Staffan Nilsson, H. Funaoka, T. Kanda, Lars-Magnus Andersson, Magnus Gisslén, A. Sonnerborg
PLoS ONE - 2013-01-01 -
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: An open-label randomized controlled
trial.
Lars-Magnus Andersson, Jan Vesterbacka, Anders Blaxhult, Leo Flamholc, Staffan Nilsson, Vidar Ormaasen, Anders Sönnerborg, Magnus Gisslén
Scandinavian journal of infectious diseases - 2013-01-01 -
Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV
Infection.
Richard W Price, Julia Peterson, Dietmar Fuchs, Thomas E Angel, Henrik Zetterberg, Lars Hagberg, Serena Spudich, Richard D Smith, Jon M Jacobs, Joseph N Brown, Magnus Gisslén
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology - 2013-01-01 -
External Validation of the Bilirubin-Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected
Patients.
Dinko Rekić, Daniel Röshammar, Martin Bergstrand, Joel Tärning, Andrea Calcagno, Antonio D'Avolio, Vidar Ormaasen, Marie Vigan, Aurélie Barrail-Tran, Michael Ashton, Magnus Gisslén, Angela Abelö
The AAPS journal - 2013-01-01 -
Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV
Infection.
Michael J Peluso, Dieter J Meyerhoff, Richard W Price, Julia Peterson, Evelyn Lee, Andrew C Young, Rudy Walter, Dietmar Fuchs, Bruce J Brew, Paola Cinque, Kevin Robertson, Lars Hagberg, Henrik Zetterberg, Magnus Gisslén, Serena Spudich
The Journal of infectious diseases - 2013-01-01 -
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral
therapy.
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, Richard W Price, Kathryn Crozier, Lars Hagberg, Serena Spudich, Magnus Gisslén
Journal of neuroinflammation - 2013-01-01 -
Cerebrospinal fluid Alzheimer's biomarker profiles in CNS
infections.
Jan Jessen Krut, Henrik Zetterberg, Kaj Blennow, Paola Cinque, Lars Hagberg, Richard W Price, Marie Studahl, Magnus Gisslén
Journal of neurology - 2013-01-01 -
Primary HIV-1 infection is characterized by elevation of cerebrospinal fluid biomarkers indicating early neuronal
damage
M. Peluso, R. Price, J. Peterson, E. Lee, D. Fuchs, B. Brew, P. Cinque, Lars Hagberg, Henrik Zetterberg, Magnus Gisslén, S. Spudich
Journal of Neurovirology - 2012-01-01 -
Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir
monotherapy.
Magnus Gisslén, Dietmar Fuchs, Lars Hagberg, Bo Svennerholm, Henrik Zetterberg
Scandinavian journal of infectious diseases - 2012-01-01 -
Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral
load
U. Karlsson, L. Antonsson, B. Ljungberg, P. Medstrand, J. Esbjornsson, M. Jansson, Magnus Gisslén
Aids - 2012-01-01 -
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral
load
M. J. Peluso, F. Ferretti, J. Peterson, E. Lee, D. Fuchs, A. Boschini, Magnus Gisslén, N. Angoff, R. W. Price, P. Cinque, S. Spudich
Aids - 2012-01-01 -
Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden
2003-2010.
Annika Karlsson, Per Björkman, Göran Bratt, Håkan Ekvall, Magnus Gisslén, Anders Sönnerborg, Mattias Mild, Jan Albert
PloS one - 2012-01-01 -
Antiretroviral drug treatment of CNS HIV-1
infection.
Aylin Yilmaz, Richard W Price, Magnus Gisslén
The Journal of antimicrobial chemotherapy - 2012-01-01 -
Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of
HIV
Tomas Mellberg, Veronica D Gonzalez, Annica Lindkvist, Arvid Edén, Anders Sönnerborg, Johan K Sandberg, Bo Svennerholm, Magnus Gisslén
AIDS Research and Therapy - 2011-01-01 -
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected
patients.
Daniel Röshammar, Ulrika S H Simonsson, Håkan Ekvall, Leo Flamholc, Vidar Ormaasen, Jan Vesterbacka, Eva Wallmark, Michael Ashton, Magnus Gisslén
Journal of pharmacokinetics and pharmacodynamics - 2011-01-01 -
The definition of HIV-associated neurocognitive disorders: are we overestimating the real
prevalence?
Magnus Gisslén, Richard W Price, Staffan Nilsson
BMC Infectious Diseases - 2011-01-01 -
Reply to
Seligman
Arvid Edén, Magnus Gisslén, Lars Hagberg, Bo Svennerholm, Serena Spudich, Richard price, Dietmar Fuchs, Staffan Nilsson
J Infect Dis - 2011-01-01 -
Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature
review.
Daniel Bremell, Christer Säll, Magnus Gisslén, Lars Hagberg
Journal of medical case reports - 2011-01-01 -
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations
2010.
Lars Navér, Jan Albert, Erik Belfrage, Leo Flamholc, Magnus Gisslén, Katarina Gyllensten, Filip Josephson, Olof Karlström, Susanne Lindgren, Karin Pettersson, Veronica Svedhem, Anders Sönnerborg, Katarina Westling, Aylin Yilmaz
Scandinavian journal of infectious diseases - 2011-01-01 -
Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral
therapy.
Dinko Rekić, Oskar Clewe, Daniel Röshammar, Leo Flamholc, Anders Sönnerborg, Vidar Ormaasen, Magnus Gisslén, Angela Abelö, Michael Ashton
The AAPS journal - 2011-01-01 -
HIV-1 infection and cognitive impairment in the cART-era: a
review.
Judith Schouten, Paola Cinque, Magnus Gisslén, Peter Reiss, Peter Portegies
AIDS - 2011-01-01 -
Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral
burden.
Serena Spudich, Magnus Gisslén, Lars Hagberg, Evelyn Lee, Teri Liegler, Bruce Brew, Dietmar Fuchs, Giuseppe Tambussi, Paola Cinque, Frederick M Hecht, Richard W Price
The Journal of infectious diseases - 2011-01-01 -
Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected
patients.
Arvid Edén, Lars-Magnus Andersson, Orjan Andersson, Leo Flamholc, Filip Josephson, Staffan Nilsson, Vidar Ormaasen, Veronica Svedhem, Christer Säll, Anders Sönnerborg, Petra Tunbäck, Magnus Gisslén
AIDS research and human retroviruses - 2010-01-01 -
HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral
treatment.
Arvid Edén, Dietmar Fuchs, Lars Hagberg, Staffan Nilsson, Serena Spudich, Bo Svennerholm, Richard W Price, Magnus Gisslén
The Journal of infectious diseases - 2010-01-01 -
Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral
Therapy.
Aylin Yilmaz, Chris Verhofstede, Antonio Dʼavolio, Victoria Watson, Lars Hagberg, Dietmar Fuchs, Bo Svennerholm, Magnus Gisslén
Journal of acquired immune deficiency syndromes (1999) - 2010-01-01 -
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1
infection.
Lars Hagberg, Paola Cinque, Magnus Gisslén, Bruce J Brew, Serena Spudich, Arabella Bestetti, Richard W Price, Dietmar Fuchs
AIDS research and therapy - 2010-01-01 -
Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in
Sweden.
Ola Ghatnekar, Catharina Hjortsberg, Magnus Gisslén, Stefan Lindbäck, Mickael Löthgren
PharmacoEconomics - 2010-01-01 -
Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept
study
Annica Lindkvist, Arvid Edén, Melissa M Norström, Veronica D Gonzalez, Staffan Nilsson, Bo Svennerholm, Annika C Karlsson, Johan K Sandberg, Anders Sönnerborg, Magnus Gisslén
AIDS research and therapy - 2009-01-01 -
Cerebrospinal fluid maraviroc concentrations in HIV-1 infected
patients
Aylin Yilmaz, V Watson, L Else, Magnus Gisslén
AIDS - 2009-01-01 -
Raltegravir cerebrospinal fluid concentrations in HIV-1
infection
Aylin Yilmaz, Magnus Gisslén, S Spudich, E Lee, A Jayewardene, F Aweeka, R. W. Price
PLoS One - 2009-01-01 -
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected
individuals
Aylin Yilmaz, Arash Izadkhasthi, R. W. Price, PW Mallon, M De Meulder, P Timmerman, Magnus Gisslén
AIDS Research and Human Retroviruses - 2009-01-01 -
Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and
plasma
T. Bergroth, H. Ekici, Magnus Gisslén, Lars Hagberg, Anders Sönnerborg
HIV Medicine - 2009-01-01 -
Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naive patients initiated on a three- or four-drug antiretroviral regimen including
lamivudine
T. Bergroth, H. Ekici, Magnus Gisslén, S. K. Loes, L. E. Goh, A. Freedman, F. Lampe, M. A. Johnson, A. Sönnerborg
Journal of medical virology - 2009-01-01 -
Treatment of HIV infection: Swedish recommendations
2009.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström, Lars Moberg, Lars Navér, Veronica Svedhem, Bo Svennerholm, Anders Sönnerborg
Scandinavian journal of infectious diseases - 2009-01-01 -
Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid
isolates.
Ulf Karlsson, Liselotte Antonsson, Johanna Repits, Patrik Medstrand, Christer Owman, Karin Kidd-Ljunggren, Lars Hagberg, Bo Svennerholm, Marianne Jansson, Magnus Gisslén, Bengt Ljungberg
AIDS research and human retroviruses - 2009-01-01 -
Amyloid and tau cerebrospinal fluid biomarkers in HIV
infection.
Magnus Gisslén, Jan Krut, Ulf Andreasson, Kaj Blennow, Paola Cinque, Bruce J Brew, Serena Spudich, Lars Hagberg, Lars Rosengren, Richard W Price, Henrik Zetterberg
BMC neurology - 2009-01-01 -
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected
patients
Filip Josephson, Maria CH Andersson, L. Flamholc, Magnus Gisslén, Lars Hagberg, Vidar Ormaasen, Anders Sönnerborg, Jan Vesterbacka, Ylva Böttiger
European Journal Clinical Pharmacology - 2009-01-01 -
Sexuellt överförbara
sjukdomar
Magnus Gisslén, G Johannisson, Karin Rignér
Läkemedelsboken 2009/2010 - 2009-01-01 -
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral
therapy
Aylin Yilmaz, R. W. Price, S. Spudich, Dietmar Fuchs, Lars Hagberg, Magnus Gisslén
Journal of Acquired Immune Deficiency Syndromes - 2008-01-01 -
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol
levels
F. Josephson, L. Bertilsson, Y. Bottiger, L. Flamholc, Magnus Gisslén, V. Ormaasen, A. Sönnerborg, U. Diczfalusy
European Journal of Clinical Pharmacology - 2008-01-01 -
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve
patients.
Leo Flamholc, Magnus Gisslén
Therapeutics and clinical risk management - 2008-01-01 -
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations
2007
L. Naver, A. B. Bohlin, J. Albert, L. Flamholc, Magnus Gisslén, K. Gyllensten, F. Josephson, P. Pehrson, A. Sönnerborg, K. Westling, S. Lindgren
Scandinavian Journal of Infectious Diseases - 2008-01-01 -
Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and
post-mortem
Eva Corina Caragounis, Magnus Gisslén, Magnus Lindh, Claes Nordborg, Stefan Westergren, Lars Hagberg, Bo Svennerholm
Acta Neurol Scand - 2008-01-01 -
Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic
subtypes
Sahra Abdulle, Lars Hagberg, Bo Svennerholm, D. Fuchs, Magnus Gisslén
PLoS ONE - 2008-01-01 -
CSF Markers in the Management of CNS HIV Infection and the AIDS Dementia
Complex
Magnus Gisslén, Lars Hagberg, Paola Cinque, Bruce J Brew, Richard W Price
The spectrum of neuro-Aids disorders. Ed: K Goodkin et al - 2008-01-01 -
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral
therapy.
Arvid Edén, Richard W Price, Serena Spudich, Dietmar Fuchs, Lars Hagberg, Magnus Gisslén
The Journal of infectious diseases - 2007-01-01 -
Antiretroviral treatment of HIV infection: Swedish recommendations
2007.
Filip Josephson, Jan Albert, Leo Flamholc, Magnus Gisslén, Olof Karlström, Susanne-Rosa Lindgren, Lars Navér, Eric Sandström, Veronica Svedhem-Johansson, Bo Svennerholm, Anders Sönnerborg
Scandinavian journal of infectious diseases - 2007-01-01 -
Biomarkers of HIV-1 CNS infection and
injury
R. W. Price, L. G. Epstein, J. T. Becker, P. Cinque, Magnus Gisslén, L. Pulliam, J. C. McArthur
Neurology - 2007-01-01 -
Updated research nosology for HIV-associated neurocognitive
disorders
A. Antinori, G. Arendt, J. T. Becker, B. J. Brew, D. A. Byrd, M. Cherner, D. B. Clifford, P. Cinque, L. G. Epstein, K. Goodkin, Magnus Gisslén, I. Grant, R. K. Heaton, J. Joseph, K. Marder, C. M. Marra, J. C. McArthur, M. Nunn, R. W. Price, L. Pulliam, K. R. Robertson, N. Sacktor, V. Valcour, V. E. Wojna
Neurology - 2007-01-01 -
Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular
Biomarkers
Magnus Gisslén, Lars Hagberg, Lars Rosengren, Bruce J Brew, Paola Cinque, S Spudich, Richard W Price
Journal of NeuroImmune Pharmacology - 2007-01-01 -
CSF neurofilament protein (NFL) - a marker of active HIV-related
neurodegeneration.
Sahra Abdulle, Åsa Mellgren, Bruce J Brew, Paola Cinque, Lars Hagberg, Richard W Price, Lars Rosengren, Magnus Gisslén
Journal of neurology - 2007-01-01 -
Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal
fluid.
Ann Atlas, Magnus Gisslén, Conny Nordin, Leif Lindström, Lilly Schwieler
Brain, behavior, and immunity - 2007-01-01 -
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia
complex.
Magnus Gisslén, Lars Hagberg, Bruce J Brew, Paola Cinque, Richard W Price, Lars Rosengren
The Journal of infectious diseases - 2007-01-01 -
Sexuellt överförbara
sjukdomar
Magnus Gisslén, G Johannisson, Karin Rignér
Läkemedelsboken 2007/2008 - 2007-01-01 -
Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia
complex
P. Cinque, B. J. Brew, Magnus Gisslén, Lars Hagberg, R. W. Price
Handb Clin Neurol - 2007-01-01 -
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1
infection
Åsa Mellgren, Richard W. Price, Lars Hagberg, Lars Rosengren, B. J. Brew, Magnus Gisslén
Neurology - 2007-01-01 -
Retroviral rebound syndrome after treatment discontinuation in a 15 year old girl with HIV attracted through mother-to-child transmission: case
report.
Vanda Friman, Magnus Gisslén
AIDS research and therapy - 2007-01-01 -
HIV och
AIDS
Magnus Gisslén
Infektionsmedicin, epidemiologi, klinik, terapi - 2007-01-01 -
Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral
therapy.
Aylin Yilmaz, Bo Svennerholm, Lars Hagberg, Magnus Gisslén
Antiviral therapy - 2006-01-01 -
Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case
report.
Lars-Magnus Andersson, Lars Hagberg, Lars Rosengren, Dietmar Fuchs, Kaj Blennow, Magnus Gisslén
BMC infectious diseases - 2006-01-01 -
A fatal case of severe immunodeficiency associated with disseminated Merulius tremellosus
infection.
Vanda Friman, Magnus Gisslén, Simo Nikkari, Jan Stenlid, Erja Chryssanthou, Björn Petrini
Scandinavian journal of infectious diseases - 2006-01-01 -
Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022
study.
Aylin Yilmaz, Dietmar Fuchs, Lars Hagberg, Ulrika Nillroth, Lars Ståhle, Jan-Olof Svensson, Magnus Gisslén
BMC infectious diseases - 2006-01-01 -
Antiretroviral treatment of HIV infection: Swedish recommendations
2005.
Magnus Gisslén, Jane Ahlqvist-Rastad, Jan Albert, Anders Blaxhult, Anna-Karin Hamberg, Stefan Lindbäck, Eric Sandström, Ingrid Uhnoo
Scandinavian journal of infectious diseases - 2006-01-01 -
Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical
transmission.
Lars Navér, Susanne Lindgren, Erik Belfrage, Katarina Gyllensten, Knut Lidman, Magnus Gisslén, Anneka Ehrnst, Malin Arneborn, Ann-Britt Bohlin
Journal of acquired immune deficiency syndromes (1999) - 2006-01-01 -
Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1
infection.
Paola Cinque, Arabella Bestetti, Roberta Marenzi, Serena Sala, Magnus Gisslén, Lars Hagberg, Richard W Price
Journal of neuroimmunology - 2005-01-01 -
Sexuellt överförbara
sjukdomar
Magnus Gisslén, G Johannisson, Karin Rignér
Läkemedelsboken 2005/2006 - 2005-01-01 -
Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected
patients.
Sahra Abdulle, Lars Hagberg, Magnus Gisslén
HIV medicine - 2005-01-01 -
Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1
infection.
Magnus Gisslén, Lars Rosengren, Lars Hagberg, Steven G Deeks, Richard W Price
AIDS research and therapy - 2005-01-01 -
Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barre
syndrome
Magnus Gisslén, Pam Fredman, Dietmar Fuchs, Annika Lekman, Lars Rosengren
Scand J Infect Dis - 2005-01-01 -
Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral
treatment.
Åsa Mellgren, Andrea Antinori, Paola Cinque, Richard W Price, Christian Eggers, Lars Hagberg, Magnus Gisslén
Antiviral therapy - 2005-01-01 -
Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2
infection.
Nicklas Arvidson, Magnus Gisslén, Jan Albert, Eleonor Brandin, Bo Svennerholm, Dietmar Fuchs, Lars Hagberg
AIDS research and human retroviruses - 2004-01-01 -
Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir
regimen.
Aylin Yilmaz, Lars Ståhle, Lars Hagberg, Bo Svennerholm, Dietmar Fuchs, Magnus Gisslén
Scandinavian journal of infectious diseases - 2004-01-01 -
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system
disease.
Nicolai Sidenius, Manuela Nebuloni, Stefania Sala, Pietro Zerbi, Richard W Price, Magnus Gisslén, Lars Hagberg, Luca Vago, Adriano Lazzarin, Francesco Blasi, Paola Cinque
Journal of neuroimmunology - 2004-01-01 -
Clinical application of cerebrospinal fluid neopterin concentrations in HIV
infection
Lars Hagberg, Lars-Magnus Andersson, Sahra Abdulle, Magnus Gisslén
PTERIDINES - 2004-01-01 -
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological
manifestations.
Paola Cinque, Manuela Nebuloni, Maria Lisa Santovito, Richard W Price, Magnus Gisslén, Lars Hagberg, Arabella Bestetti, Gianluca Vago, Adriano Lazzarin, Francesco Blasi, Nicolai Sidenius
Annals of neurology - 2004-01-01 -
Antiretroviral treatment of human immunodeficiency virus infection: Swedish
recommendations
Eric Sandström, Ingrid Uhnoo, Jane Ahlqvist-Rastad, Göran Bratt, Torsten Berglund, Magnus Gisslén, Stefan Lindbäck, Linda Morfeldt, Lars Ståhle, Anders Sönnerborg
Scand J Infect Dis - 2003-01-01 -
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral
therapy
Eleonor Brandin, Lena Lindborg, Katarina Gyllensten, Christina Broström, Lars Hagberg, Magnus Gisslén, Björn Tuvesson, Anders Blaxhult, Jan Albert
AIDS Res Hum Retroviruses - 2003-01-01 -
Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1
infection
Sahra Abdulle, Lars Hagberg, Bo Svennerholm, Dietmar Fuchs, Magnus Gisslén
Aids - 2002-01-01 -
[Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good
result]
Magnus Gisslén, Anders Sönnerborg
Läkartidningen - 2002-01-01 -
Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin
levels
Lars-Magnus Andersson, Lars Hagberg, Dietmar Fuchs, Bo Svennerholm, Magnus Gisslén
J Neurovirol - 2001-01-01 -
Antiretroviral treatment of central nervous system HIV-1 infection: a
review
Magnus Gisslén, Lars Hagberg
HIV Med - 2001-01-01 -
Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after
treatment
Magnus Sjögren, Magnus Gisslén, E. Vanmechelen, Kaj Blennow
Neurosci Lett - 2001-01-01 -
Higher HIV-1 RNA cutoff level required in cerebrospinal fluid than in blood to predict positive HIV-1
isolation
Lars-Magnus Andersson, Bo Svennerholm, Lars Hagberg, Magnus Gisslén
J Med Virol - 2000-01-01 -
Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment
regimens
Magnus Gisslén, Bo Svennerholm, Gunnar Norkrans, Christer Franzén, Christer Säll, Rune Svensson, Sven Öberg, Lars Hagberg
Scand J Infect Dis - 2000-01-01 -
Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1
infection
Magnus Gisslén, Annika Lekman, Pam Fredman
Infection - 2000-01-01 -
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS
patients
Lars Hagberg, Dietmar Fuchs, Lars Rosengren, Magnus Gisslén
J Neuroimmunol - 2000-01-01 -
Slowed reaction time in HIV-1-infected patients without
AIDS
Åsa Mellgren, Gunnar Norkrans, Lars Hagberg, O. Dunlop, Rune Wejstål, Magnus Gisslén
Acta Neurol Scand - 2000-01-01 -
Increased cerebrospinal fluid protein tau concentration in
neuro-AIDS
Lars-Magnus Andersson, Kaj Blennow, Dietmar Fuchs, Bo Svennerholm, Magnus Gisslén
J Neurol Sci - 1999-01-01 -
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1
infection
Magnus Gisslén, Dietmar Fuchs, Bo Svennerholm, Lars Hagberg
J Acquir Immune Defic Syndr - 1999-01-01 -
Kinetics of HIV-1 in cerebrospinal fluid and serum after zidovudine
treatment
Lars Hagberg, Magnus Gisslén, Gunnar Norkrans, Bo Svennerholm
J NeuroAIDS - 1999-01-01 -
High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system
complications
Magnus Gisslén, Annika Lekman, Pam Fredman
J Neuroimmunol - 1999-01-01 -
Neurological efficacy of stavudine, zidovudine, and
lamivudine
Magnus Gisslén, Bo Svennerholm, Dietmar Fuchs, Lars Hagberg
Lancet - 1998-01-01 -
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and
indinavir
Magnus Gisslén, Gunnar Norkrans, Bo Svennerholm, Lars Hagberg
Aids - 1998-01-01 -
Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal
study
Magnus Gisslén, Lars Hagberg, Dietmar Fuchs, Gunnar Norkrans, Bo Svennerholm
J Acquir Immune Defic Syndr Hum Retrovirol - 1998-01-01 -
Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1
infection
Lars-Magnus Andersson, Pam Fredman, Annika Lekman, Lars Rosengren, Magnus Gisslén
AIDS Res Hum Retroviruses - 1998-01-01 -
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or
didanosine
Magnus Gisslén, Gunnar Norkrans, Bo Svennerholm, Lars Hagberg
J Infect Dis - 1997-01-01 -
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination
therapy
Magnus Gisslén, Lars Hagberg, Bo Svennerholm, Gunnar Norkrans
Aids - 1997-01-01 -
Increased cerebrospinal fluid ganglioside GM1 concentrations indicating neuronal involvement in all stages of HIV-1
infection
Magnus Gisslén, Lars Hagberg, Gunnar Norkrans, Annika Lekman, Pam Fredman
J Neurovirol - 1997-01-01 -
Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by
didanosine
Lars Hagberg, Gunnar Norkrans, Magnus Gisslén, Helmut Wachter, Dietmar Fuchs, Bo Svennerholm
Scand J Infect Dis - 1996-01-01 -
Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I
infection
Magnus Gisslén, Pam Fredman, Gunnar Norkrans, Lars Hagberg
AIDS Res Hum Retroviruses - 1996-01-01 -
Increase of tryptophan in serum and in cerebrospinal fluid of patients with HIV infection during zidovudine
therapy
Dietmar Fuchs, Magnus Gisslén, M. Larsson, Gunnar Norkrans, Lars Hagberg, Helmut Wachter
Adv Exp Med Biol - 1996-01-01 -
Cerebrospinal fluid markers of HIV-1 infection and effects of antiviral
treatment
Magnus Gisslén
- 1996-01-01 -
Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal
study
Magnus Gisslén, Francesca Chiodi, Dietmar Fuchs, Gunnar Norkrans, Bo Svennerholm, Helmut Wachter, Lars Hagberg
Scand J Infect Dis - 1994-01-01 -
Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1
infection
Magnus Gisslén, M Larsson, Gunnar Norkrans, Dietmar Fuchs, Helmut Wachter, Lars Hagberg
AIDS Res Hum Retroviruses - 1994-01-01 -
GM-CSF expands the eosinophilic compartment in chronic idiopathic
neutropenia
Rune Andersson, B. Elgefors, Börje Ridell, Magnus Gisslén, Jack Kutti
Eur J Haematol - 1990-01-01